Taiho Oncology Announces Decitabine and Cedazuridine to be Included in NIH Precision Medicine Trials
Press Releases
Taiho Oncology  
January 14, 2025

Taiho Oncology Announces Decitabine and Cedazuridine to be Included in NIH Precision Medicine Trials

Drug combination part of next-generation trials targeting specific genetic mutations in patients with myelodysplastic syndromes and acute myeloid leukemia

avatar profile Olean Times Herald

Olean Times Herald


Local & Social